Oxtriphylline

胆茶碱

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameOxtriphylline
Drug Alias NameCholine theophyllineCholine theophyllinateTheocolin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonistsPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4Adenosine A1 receptorAdenosine A2a receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCanada
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesParke Davis Pharmaceutical Research Div Warner Lambert Co
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeR03DA02
Related LinksWikipediaDrugBankKEGG